HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chen Qing Selected Research

Gibberellins

12/2020Chronic exposure to the gibberellin derivative GA-13315 sensitizes breast cancer MCF-7 cells but not colon cancer HCT116 cells to irinotecan.
1/2019Anti-tumor effects and mechanism of GA-13315, a novel gibberellin derivative, in human lung adenocarcinoma: an in vitro and in vivo study.
1/2016Gibberellin derivative GA-13315 sensitizes multidrug-resistant cancer cells by antagonizing ABCB1 while agonizes ABCC1.
9/2009Synthesis of gibberellin derivatives with anti-tumor bioactivities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chen Qing Research Topics

Disease

23Neoplasms (Cancer)
05/2022 - 09/2004
3Adenocarcinoma of Lung
01/2019 - 02/2008
3Neoplasm Metastasis (Metastasis)
11/2017 - 08/2013
3Leukemia
07/2016 - 05/2003
2Prostatic Neoplasms (Prostate Cancer)
12/2020 - 01/2017
2Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 11/2017
2Lung Neoplasms (Lung Cancer)
01/2019 - 05/2008
2Burkitt Lymphoma (Burkitt's Lymphoma)
12/2013 - 01/2011
1Carcinoma (Carcinomatosis)
05/2022
1Hepatocellular Carcinoma (Hepatoma)
05/2022
1Wounds and Injuries (Trauma)
02/2021
1Hypersensitivity (Allergy)
02/2021
1Ischemic Stroke
01/2021
1Colonic Neoplasms (Colon Cancer)
12/2020
1Breast Neoplasms (Breast Cancer)
12/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Type 2 Diabetes Mellitus (MODY)
09/2018
1Circulating Neoplastic Cells
11/2017
1Inflammation (Inflammations)
12/2016
1Chronic Obstructive Pulmonary Disease (COPD)
12/2016
1Sarcoma (Soft Tissue Sarcoma)
07/2016
1Colorectal Neoplasms (Colorectal Cancer)
03/2016
1Hypoxia (Hypoxemia)
04/2015
1Acidosis
11/2013
1Ischemia
11/2013
1Familial primary gastric lymphoma
09/2012
1Acute Lung Injury
06/2011
1Acute Promyelocytic Leukemia
01/2011
1Lymphoma (Lymphomas)
12/2008
1Lymphoid Leukemia
05/2008

Drug/Important Bio-Agent (IBA)

4Biological ProductsIBA
05/2022 - 01/2011
4GibberellinsIBA
12/2020 - 09/2009
413-chlorine-3,15-dioxy-gibberellic acid methyl esterIBA
12/2020 - 02/2012
3Arsenic Trioxide (Trisenox)FDA Link
12/2013 - 12/2008
2Type I DNA Topoisomerases (Topoisomerase I)IBA
05/2022 - 09/2004
2trioctyl phosphine oxide (TOPO)IBA
05/2022 - 09/2004
2linaloolIBA
12/2020 - 01/2017
2Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2020 - 01/2017
2AcidsIBA
01/2019 - 11/2013
2DNA (Deoxyribonucleic Acid)IBA
11/2017 - 09/2004
2salvicineIBA
08/2013 - 05/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2012 - 02/2012
1Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2022
1ProdrugsIBA
05/2022
1Cisplatin (Platino)FDA LinkGeneric
05/2022
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2022
1rubitecanIBA
05/2022
1CamptothecinIBA
05/2022
1Caspase 3 (Caspase-3)IBA
05/2022
1Biomarkers (Surrogate Marker)IBA
07/2021
1Interleukin-2 Receptors (IL 2 Receptor)IBA
12/2020
1Interleukin-2 (IL2)IBA
12/2020
1Irinotecan (Camptosar)FDA LinkGeneric
12/2020
1AntibodiesIBA
12/2020
1RNA (Ribonucleic Acid)IBA
10/2020
1Tight Junction ProteinsIBA
10/2020
1EstersIBA
01/2019
1Sirtuin 1IBA
09/2018
1Circulating Tumor DNAIBA
11/2017
1Cell-Free Nucleic AcidsIBA
11/2017
1TransferasesIBA
01/2017
1linalyl acetateIBA
01/2017
1ParaffinIBA
01/2017
1Volatile Oils (Essential Oils)IBA
01/2017
1NucleotidesIBA
12/2016
1InflammasomesIBA
12/2016
1SmokeIBA
12/2016
126-deoxyacteinIBA
07/2016
1acteinIBA
07/2016
1bisleuconothine AIBA
03/2016
1CateninsIBA
03/2016
1CaspasesIBA
03/2016
1AlkaloidsIBA
03/2016
1scutellarinIBA
04/2015
1Messenger RNA (mRNA)IBA
12/2013
1Proteins (Proteins, Gene)FDA Link
12/2013
1Nifedipine (Adalat)FDA LinkGeneric
11/2013
1IntegrinsIBA
08/2013
1Factor VIII (Coagulation Factor VIII)IBA
02/2012
1(23R,24S)- 16,23- 16,24- diepoxy- 9,19- cyclolanostan- 3beta,15alpha,25- triolIBA
01/2012
1LipopolysaccharidesIBA
06/2011
1CytokinesIBA
06/2011
1Interleukin-8 (Interleukin 8)IBA
06/2011
1EndotoxinsIBA
06/2011
1Interleukin-6 (Interleukin 6)IBA
06/2011
1Pharmaceutical PreparationsIBA
01/2011
1KetonesIBA
09/2009
1asclepinIBA
04/2009
1Carboplatin (JM8)FDA LinkGeneric
05/2008
1BromidesIBA
02/2008
1LactonesIBA
02/2008

Therapy/Procedure

5Therapeutics
07/2021 - 09/2012
1Oral Administration
05/2022
1Intravenous Injections
05/2022
1Drug Therapy (Chemotherapy)
07/2021
1Radiotherapy
07/2021
1Sutures (Suture)
02/2021
1Rhytidoplasty (Facelift)
02/2021
1Thrombectomy
01/2021
1Transplantation
01/2017